Brown Kieron, Long Joanna M, Vial Sarah C M, Dedi Neesha, Dunster Nicholas J, Renwick Suzanne B, Tanner Adam J, Frantz J Dan, Fleming Mark A, Cheetham Graham M T
Vertex Pharmaceuticals (Europe) Ltd., 88 Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom.
J Biol Chem. 2004 Apr 30;279(18):18727-32. doi: 10.1074/jbc.M400031200. Epub 2004 Feb 6.
Interleukin-2 tyrosine kinase, Itk, is an important member of the Tec family of non-receptor tyrosine kinases that play a central role in signaling through antigen receptors such as the T-cell receptor, B-cell receptor, and Fcepsilon. Selective inhibition of Itk may be an important way of modulating many diseases involving heightened or inappropriate activation of the immune system. In addition to an unliganded nonphophorylated Itk catalytic kinase domain, we determined the crystal structures of the phosphorylated and nonphosphorylated kinase domain bound to staurosporine, a potent broad-spectrum kinase inhibitor. These structures are useful for the design of novel, highly potent and selective Itk inhibitors and provide insight into the influence of inhibitor binding and phosphorylation on the conformation of Itk.
白细胞介素-2酪氨酸激酶(Itk)是Tec家族非受体酪氨酸激酶的重要成员,该家族在通过抗原受体(如T细胞受体、B细胞受体和Fcepsilon)进行信号传导中起核心作用。选择性抑制Itk可能是调节许多涉及免疫系统过度激活或不适当激活的疾病的重要方式。除了未结合配体的非磷酸化Itk催化激酶结构域外,我们还确定了与强效广谱激酶抑制剂星形孢菌素结合的磷酸化和非磷酸化激酶结构域的晶体结构。这些结构有助于设计新型、高效且选择性的Itk抑制剂,并深入了解抑制剂结合和磷酸化对Itk构象的影响。